Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 939-707-2 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Repeated dose toxicity: inhalation
Administrative data
- Endpoint:
- short-term repeated dose toxicity: inhalation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- no data available
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: The study is sufficiently documented. OECD Guideline study; analytical purity of test substance: 68,3%.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 990
- Report date:
- 1990
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 412 (Subacute Inhalation Toxicity: 28-Day Study)
- Deviations:
- no
- GLP compliance:
- yes
- Limit test:
- no
Test material
- Reference substance name:
- sodium diisobutylnaphtalene sulfonate
- Cas Number:
- 91078-64-7
- IUPAC Name:
- sodium diisobutylnaphtalene sulfonate
- Test material form:
- solid: particulate/powder
- Remarks:
- migrated information: powder
- Details on test material:
- See confidential details on test material section
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Dr. K Thomae GmbH
- Age at study initiation: about 7 weeks
- Weight at study initiation: males: mean = 230 g; females: mean = 177 g
- Housing: single
- Diet: ad libitum during post exposure observation period
- Water: ad libitumduring post exposure observation period
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20 - 24
- Humidity (%): 30 - 70
- Photoperiod (hrs dark / hrs light): 12/12
Administration / exposure
- Route of administration:
- other: Inhalation: dust aerosol
- Type of inhalation exposure:
- nose/head only
- Vehicle:
- air
- Remarks on MMAD:
- MMAD / GSD: 0.8 mg/m³: 3.3 µm
8 mg/m³: 3.3 µm
80 mg/m³: 3.1 µm - Details on inhalation exposure:
- GENERATION OF TEST ATMOSPHERE / CHAMBER DESCRIPTION
- Exposure apparatus: aerodynamic exposure apparatus (INA 60, Volume ca. 90 L, BASF AG)
- Method of holding animals in test chamber: The rats were restrained in exposure tubes (glass tubes), their snouts projected into the inhalation chamber and they thus inhaled the dust aerosol.
- System of generating particulates/aerosols: brush generator
- Temperature, humidity, pressure in air chamber: 22°C, 50% humidity
- Method of particle size determination: cascade imapactor
TEST ATMOSPHERE
- Brief description of analytical method used: Spectrophotometric analysis
- Samples taken from breathing zone: yes - Analytical verification of doses or concentrations:
- yes
- Details on analytical verification of doses or concentrations:
- no data available
- Duration of treatment / exposure:
- 6 hours per day for 28 days
- Frequency of treatment:
- 5 days per week
Doses / concentrationsopen allclose all
- Remarks:
- Doses / Concentrations:
0, 0.8, 8, 80 mg/m³
Basis:
nominal conc.
- Remarks:
- Doses / Concentrations:
0, 0.86, 8.1, 82 mg/m³
Basis:
analytical conc.
- No. of animals per sex per dose:
- 5
groups of female rats (5 animals) were hold without further exposure for an about 4-week post exposure - Control animals:
- yes, concurrent vehicle
- Details on study design:
- no data available
- Positive control:
- no data available
Examinations
- Observations and examinations performed and frequency:
- CAGE SIDE OBSERVATIONS: Yes
- Time schedule: daily
- Cage side observations: mortality, behavior and state of health
DETAILED CLINICAL OBSERVATIONS: No
OPHTHALMOSCOPIC EXAMINATION: No
BODY WEIGHT: Yes
- Time schedule for examinations: each week
HAEMATOLOGY: Yes
- Time schedule for collection of blood: after 28 day exposure period and after post-exposure observation period
- Anaesthetic used for blood collection: No data
- Animals fasted: No
- How many animals: all
- Parameters checked: leukocytes, erythrocytes, hemoglobin, hematocrit, mean corpuscular volume, mean corpuscular hemoglobin, mean corpuscular hemoglobin concentration, platelets, differential blood count, thromboplastin time
CLINICAL CHEMISTRY: Yes
- Time schedule for collection of blood: after 28 day exposure period and after post-exposure observation period
- Animals fasted: No
- How many animals: all
- Parameters checked: alanine aminotransferase, aspartate aminotransferase, alkaline phosphatase, sodium, potassium, chloride, inorganic phosphate, calcium, urea, creatinine, glucose, total bilirubin, total protein, albumin, globulins, triglycerides, cholesterol
URINALYSIS: No
NEUROBEHAVIOURAL EXAMINATION: No - Sacrifice and pathology:
- GROSS PATHOLOGY: Yes
HISTOPATHOLOGY: Yes - Other examinations:
- None
- Statistics:
- Clinical examinations
Means and standard deviation were calculated for the variables (body weight and body weight gain/body weight change) of the animais of each test group for the statistical evaluation of the study. Statistical relevance was established using methods of ANOVA and DUNNETT.
Clinical chemistry and hematology
Mean and standard deviation were calculated for each test group and tabulated together with the individual values.
Except of the differential blood count, a non-parametric one-way analysis of variance is done via the Kruskal-Wallis-h-test. If the resulting p-value is equal or less than 0.05 a pairwise comparison of each dose group with the control group was carried out. This comparison is done using the Mann-Whitney-U-test for the hypotheses of equal medians.
Results and discussion
Results of examinations
- Clinical signs:
- no effects observed
- Mortality:
- no mortality observed
- Body weight and weight changes:
- effects observed, treatment-related
- Description (incidence and severity):
- statistically significant retarded body weight change in male rats
- Food consumption and compound intake (if feeding study):
- not specified
- Food efficiency:
- not specified
- Water consumption and compound intake (if drinking water study):
- not specified
- Ophthalmological findings:
- not examined
- Haematological findings:
- no effects observed
- Clinical biochemistry findings:
- no effects observed
- Urinalysis findings:
- not examined
- Behaviour (functional findings):
- not examined
- Organ weight findings including organ / body weight ratios:
- effects observed, treatment-related
- Gross pathological findings:
- no effects observed
- Histopathological findings: non-neoplastic:
- effects observed, treatment-related
- Histopathological findings: neoplastic:
- effects observed, treatment-related
- Details on results:
- CLINICAL SIGNS AND MORTALITY:
80 mg/m³: no substance related effects
8 mg/m³: no substance related effects
0.8 mg/m³: no substance related effects
No mortalities were recorded throughout the exposure period.
BODY WEIGHT AND WEIGHT GAIN:
80 mg/m³: statistically significant retarded body weight change in male rats
8 mg/m³: no substance related effects
0.8 mg/m³: no substance related effects
HAEMATOLOGY:
all groups: no substance related effects
CLINICAL CHEMISTRY:
80 mg/m³: no substance related effects; 8 mg/m³: no substance related effects; 0.8 mg/m³: no substance related effects
ORGAN WEIGHTS:
80 mg/m³: increased absolute and relative lung weights (females and males); in the post exposure observation group a trend towards increased absolute and relative lung weights were still seen
8 mg/m³: increased absolute and relative lung weights which was still apparent in the post exposure observation group
0.8 mg/m³: no substance related effects
GROSS PATHOLOGY:
80 mg/m³: no substance related effects; 8 mg/m³: no substance related effects; 0.8 mg/m³: no substance related effects
HISTOPATHOLOGY:
80 mg/m³: lungs: hypertrophy of goblet cells (male and females), interstitial pneumonitis (increased in grading; males and females), increased connective tissue content (males and females)
nasal cavity (level 1): focal metaplasia of the respiratory epithelium (males and females)
post exposure observation period: increased connective tissue content lungs
8 mg/m³: no substance related effects
0.8 mg/m³: no substance related effects
Effect levels
open allclose all
- Dose descriptor:
- NOAEL
- Remarks:
- local
- Effect level:
- 0.86 mg/m³ air (analytical)
- Based on:
- test mat.
- Remarks:
- (equivalent to the substance as registered)
- Sex:
- male/female
- Basis for effect level:
- other: based on the absence of local effects
- Dose descriptor:
- LOAEL
- Remarks:
- local
- Effect level:
- 8.1 mg/m³ air (analytical)
- Based on:
- test mat.
- Remarks:
- (equivalent to the substance as registered)
- Sex:
- male/female
- Basis for effect level:
- other: based on the effects on lung weight
- Dose descriptor:
- NOAEL
- Remarks:
- systemic
- Effect level:
- 82 mg/m³ air (analytical)
- Based on:
- test mat.
- Remarks:
- (equivalent to the substance as registered)
- Sex:
- male/female
- Basis for effect level:
- other: based on the absence of toxicologically significant systemic effects
Target system / organ toxicity
- Critical effects observed:
- not specified
Applicant's summary and conclusion
- Conclusions:
- In a repeated dose inhalation toxicity study conducted according to OECD Guideline 412 (1990), groups of male and female Wistar rats (5/sex) were exposed by the inhalation route to the test substance as dust aerosol for 6 hours per day on 5 days per week for 4 weeks (28-day test) to head/nose at concentrations of 0, 0.8, 8, 80 mg/m³ (nominal concentrations) or 0, 0.86, 8.1, 82 mg/m³ (analytical concentrations). Based on the results of this study, 82 mg/m³ of test item was established as the No Observed Adverse Effect Level (NOAEL) systemic based on the absence of toxicologically significant systemic effects; 0,86 mg/m³ of test item was established as the No Observed Adverse Effect Level (NOAEL) local and 8.1 mg/m³ of test item was established as the Lowest Observed Adverse Effect Level (LOAEL) local based on the effects on lung weight. Therefore, reaction product of naphthalene, butanol, sulfonated and neutralized by caustic soda is not classified for repeated dose toxicity according to the classification criteria of the Regulation (EC) 1272/2008 (CLP) and of the Directive 67/548/EEC.
- Executive summary:
In a repeated dose inhalation toxicity study according to OECD Guideline 412 (1990), groups of male and female Wistar rats (5/sex) were exposed by the inhalation route to the test substance as dust aerosol for 6 hours per day on 5 days per week for 4 weeks (28-day test) to head/nose at concentrations of 0, 0.8, 8, 80 mg/m³ (nominal concentrations) or 0, 0.86, 8.1, 82 mg/m³ (analytical concentrations). Groups of 5 female rats were hold without further exposure for an about 4-week post-exposure observation period to obtain informations on persistency, progression or regression of effects.
No mortality and no clinical signs were reported throughout the study whatever the dose level. Body weight gain was reduced in high dose males only. There were no test item-related effects on hematology and clinical chemistry parameters at any dose levels. No macroscopic findings were reported at necropsy. An increase of absolute and relative lung weights in male animals was observed at 82 mg/m³ and in female animals at 8.1 and 82 mg/m³. Histopathologically, goblet cell hyperplasia was reported in the bronchi of both sexes at 82 mg/m³. Furthermore, the grade of severity of pneumonitis that occurred also in control animals was slightly increased in the animals at 82 mg/m³, as was there a slight increase in the content of connective tissue of the lungs. In the nasal cavity, focal metaplasia of the respiratory epithelium to stratifying epithelium was noted in the animals at 82 mg/m³ at the transition of the stratifying epithelium to respiratory epithelium. After a 4-week recovery period (females only), the lungs of the animals at 82 mg/m³ showed only a slight reparative increase of mature connective tissue. Focal metaplasia in the nasal cavity was evident in only 2 animals at 82 mg/m³.
Based on the results of this study, 82 mg/m³ of test item was established as the No Observed Adverse Effect Level (NOAEL) systemic based on the absence of toxicologically significant systemic effects; 0,86 mg/m³ of test item was established as the No Observed Adverse Effect Level (NOAEL) local and 8.1 mg/m³ of test item was established as the Lowest Observed Adverse Effect Level (LOAEL) local based on the effects on lung weight.
Therefore, reaction product of naphthalene, butanol, sulfonated and neutralized by caustic soda is not classified for repeated dose toxicity according to the classification criteria of the Regulation (EC) 1272/2008 (CLP) and of the Directive 67/548/EEC.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
